Veículo
Annapolis News Updates
Em 2026: 2 notícias
Desde 1995: 3 notícias
Dengue Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight
Publicado em 24 de abril de 2026
DelveInsight’s, “Dengue Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Dengue pipeline landscape. It covers the Dengue pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Dengue therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our [...]
-
Dengue Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Publicado emDelveInsight’s, “Dengue Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Dengue pipeline landscape. It covers the Dengue pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Dengue therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our [...]ver notícia -
Dengue Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight
Publicado em 02 julho 2024DelveInsight’s, “Dengue- Pipeline Insight 2024” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Dengue pipeline landscape. It covers the Dengue pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest [...]ver notícia